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ABSTRACT The fragment Ab(25–35) of the Alzheimer’s amyloid b -peptide, like its full-length peptide Ab(1–42), has shown
neurotoxic activities in cultured cells. The conformational preference of this important peptide is examined here in solution, gel,
and ﬁlm states (obtained with organic and aqueous solvents) by vibrational circular dichroism spectroscopy for the ﬁrst time. For
comparative studies, vibrational absorption and electronic circular dichroism measurements were also carried out under
identical conditions. The peptide was found to adopt b-sheet and b-turn structures, with their relative proportions changing in
different environments.
INTRODUCTION
Amyloid b (Ab) peptide is a proven major contributing
component of neuritic plaques of Alzheimer’s disease (AD)
(Sambamurthi et al., 2002; Behl, 1997). The formation of
ﬁbrillar deposits of Ab peptide in brain is a key step in the
pathogenesis of this disease, since the conversion of Ab from
soluble monomer to insoluble ﬁbril is considered to cause the
neuronal degeneration and clinical dementia in AD patients.
Recent biophysical studies such as electron microscopy,
solid-state NMR, Fourier transform infrared (FTIR), and
electronic circular dichroism (ECD) spectra indicated that
the Ab ﬁbrils exhibit a high b-sheet content (Serpell, 2000;
May et al., 1992; Mager, 1998). The conversion of normal
Ab peptides with water-soluble a-helical/random coil
structures into the insoluble Ab aggregates with an extensive
b-sheet content is considered to be the predominant event in
the onset of AD. The normal Ab peptides with a-helical
conformations are reported as being nontoxic or less toxic,
but the neurotoxicity is observed to increase with the
formation of b-sheet structure (Behl, 1997; May et al., 1992;
Simmons et al., 1994). It has been reported that Ab
ﬁbrillogenesis is kinetically dependent on the nucleation-
dependent polymerization (Lomakin et al., 1997). However,
the exact mechanism of Ab aggregation is not yet clear. The
full-length Ab peptide, which is responsible for AD,
contains 42 amino acid residues. The interesting property
of Ab peptide is that its various fragments (with residues
1–28 (Burdick et al., 1992), 25–35 (Pike et al., 1995), and
34–42 (Halverson et al., 1990)) also show similar bio-
physical and biochemical properties as those of full-length
Ab(1–42) peptide.
Spectroscopic measurements provide powerful pathways
to analyze the secondary structure of peptides, polypeptides,
and proteins in different microenvironments. FTIR and ECD
spectroscopies were widely used (Pelton and McLean, 2000;
Lin et al., 2003) for secondary structural analyses. Most
optical spectroscopic secondary structure studies of peptides
involve the use of ECD measured for the n-p* and p-p*
transitions of the amide linkage (Yang et al., 1986; Johnson,
1985; Manning, 1989). On the other hand, the FTIR method
is based on the assignment of vibrational band positions to
different secondary structures. The carbonyl stretching bands
from the amide group, referred to as Amide I bands,
appearing in the 1700–1600 cm1 region were frequently
used for the assignment of different secondary structures of
biomolecules, since this Amide I band position was noted to
depend on the type of structure (Haris and Chapman, 1995;
Cooper and Knutson, 1995).
A new vibrational spectroscopy technique, vibrational
circular dichroism (VCD) spectroscopy, has emerged re-
cently, which differentiates among different secondary
structures of proteins and peptides in aqueous and non-
aqueous solvent conditions (Keiderling, 2002; Baumruk and
Keiderling, 1993; Pancoska et al., 1989; Polavarapu and
Zhao, 2000; Zhao et al., 2000; Zhao and Polavarapu, 2001;
Yoder et al., 1995). VCD measures the difference in
absorbance for left and right circularly polarized infrared
radiation. Keiderling and coworkers carried out a series of
VCD studies to analyze the conformational preference of
polypeptides in solution and thin ﬁlm state (Keiderling,
1986; Hilario et al., 2003; Yasui and Keiderling, 1986;
Keiderling et al., 1999; Keiderling and Xu, 2002; Narayanan
et al., 1986, 1985). Other research groups have also reported
the VCD of several peptides and polypeptides under
different conditions (Wang and Polavarapu, 2003; Eker
et al., 2002; Borics et al., 2003; Urbanova et al., 2001).
This study addresses the question of the structure of
Ab(25–35) peptide, one of the active fragments of Ab(1–42)
peptide, at higher concentration in membraneous (methanol),
aggregated (acidic solution), and nonaggregated (dimethyl-
sulfoxide, DMSO) conditions using VCD spectroscopy for
the ﬁrst time. The amino acid sequence of Ab(25–35)
peptide is NH2-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-
Met-COOH, where the ﬁrst Gly represents the amino acid 25
and the last Met represents the amino acid 35. The Ab(25–
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35) peptide is also investigated in gel state for the ﬁrst time.
Comparative studies are also carried out using vibrational
absorption and ECD. The conformational preference of
Ab(25–35) peptide ﬁlm is also investigated using vibrational
absorption and VCD spectroscopy.
EXPERIMENTAL
All ﬂuorenyl-9-methoxycarbonyl (Fmoc)-amino acids, pentaﬂuorophenol,
and Wang resin were purchased from Nova Biochem (San Diego, CA).
Ab(25–35) peptide was synthesized by manual solid-phase methodology
on Wang resin using standard procedures (Chan and White, 2000). The
required Fmoc N-protected amino acids were converted into their active
esters using pentaﬂuorophenol, except for serine amino acid (followed by
anhydride method). 1-hydroxybenzotriazole hydrate was used during the
coupling of active ester of Fmoc-amino acids. Fmoc deprotection was
achieved with 20% (v/v) piperidine in N, N-dimethylformamide. Peptidyl-
resin was cleaved with a mixture of triﬂuoroacetic acid, ethanedithiol,
thioanisole, and anisole in the ratio 90:3:5:2, respectively. After cleavage,
the resin was removed by ﬁltration and the crude peptide was isolated by
precipitation from the cleavage solution by the addition of cold ether. The
identity and purity of the peptide was assessed by matrix-assisted laser
desorption ionization time-of-ﬂight mass spectrometry (theoretical MW ¼
1060.8; experimental MW ¼ 1060) and reverse-phase high-performance
liquid chromatography (HPLC), respectively. High pure methanol (HPLC
grade) was used for spectroscopic measurements.
Vibrational circular dichroism
All VCD spectra were recorded on a commercial Chiralir spectrometer
(Bomem-BioTools, Quebec, Canada) modiﬁed to minimize the artifacts
using double polarization modulation method (Naﬁe, 2000). These
modiﬁcations are as follows: the light from interferometer, brought to an
external bench using a BaF2 lens, is passed through a linear polarizer,
photoelastic modulator (PEM), sample, a second PEM, ZnSe focusing lens,
and to the detector. The detector signal is processed by two electronic paths.
In one, the low-frequency signal is isolated with a low-pass ﬁlter and
Fourier-transformed. In the second path, the high frequency component is
isolated with a high pass ﬁlter and analyzed with two lock-in ampliﬁers. One
lock-in ampliﬁer is tuned to the frequency (37.07 kHz) of the ﬁrst PEM and
the second lock-in ampliﬁer is tuned to the frequency (36.95 kHz) of the
second PEM. The outputs of these lock-in ampliﬁers are fed to a low-pass
ﬁlter, subtracted, and Fourier-transformed. All spectra were collected at
a resolution of 8 cm1 with 1 h data acquisition time except for ﬁlm, where
20-min acquisition was used.
For solution VCD measurements, stock solutions (10 mg/mL) of Ab(25–
35) were prepared using methanol-d or DMSO-d6 solvent. For time-
dependent VCD measurements methanol solvent was used. The baseline for
peptide VCD spectra was obtained from the corresponding VCD spectrum
of solvent obtained under the same conditions. For infrared (IR) absorption
spectra, the solvent spectra were subtracted from the solution spectra.
For the gel VCD measurements, ;25–30 mL of gel obtained from aged
solution (10 mg/mL) in methanol-d or acetate buffer was placed between
two CaF2 plates (2.5 cm diameter) to give an absorbance between 0.3 and
0.6 for the dominant amide I band. The acetate buffer (pD 3) used here was
prepared using D2O solution. For IR absorption spectra, the solvent spectra
were subtracted from gel spectra until the characteristic solvent absorption
band was removed. The VCD baseline was obtained from the VCD of
a blank CaF2 window obtained under the same conditions as the gel VCD
spectra.
For the ﬁlm VCD measurements, ;150 mL of Ab(25–35) peptide stock
solution (10 mg/mL) in methanol-d was cast onto a 2.5-cm diameter CaF2
window. The evaporation was continued at room temperature until a dry ﬁlm
was formed on the CaF2 window. Film samples were tested for satisfactory
VCD characteristics by rotating the ﬁlm through 90, 180, and 270 about
the light beam axis. For all data reported here, the VCD sign pattern is
independent of the rotational position of the ﬁlm. The baseline for the VCD
spectrum was obtained from the VCD of a blank CaF2 window obtained
under the same conditions as those used for obtaining the ﬁlm VCD
spectrum.
Electronic circular dichroism
All ECD measurements were made on JASCO J720 spectropolarimeter
at 25C. The instrument was calibrated with ammonium d-camphor-10-
sulfonate. All spectra reported in this study are an average of three individual
scans. For solution ECD measurements, a concentration of 5 mg/mL or 10
mg/mL in methanol solvent or acetate buffer (pH 3) and a 0.01-cm circular
quartz cell were used. The acetate buffer was prepared using H2O solution.
The spectra were recorded at a scan speed of 20 nm/min and a time constant
of 0.125 s. The parameters like bandwidth of 1 nm, resolution of 1 nm, and
sensitivity of 100 mdeg were ﬁxed before recording the spectra. The
corresponding solvent spectrum was subtracted from the ECD spectrum
of peptide solution. The resulting spectra were further processed for
smoothening when needed. The kinetics of Ab(25–35) peptide aggregation
was monitored by recording the ECD spectra at different time intervals. For
gel ECD measurements, ;20 mL of gel was placed between two circular
quartz windows. Measurements were carried out for the gels that are formed
from solutions containing 5 and 10 mg/mL. The parameters for recording the
gel-state ECD spectra were the same as those for recording the solution
spectra except for a time constant of 0.5 s, scan speed of 50 nm/min, and
sensitivity of 50 mdeg. For all samples under the above conditions, the HT
voltage remained well within the limits required for a reliable measurement.
RESULTS AND DISCUSSION
Conformation of Ab(25–35) in solution state
The VCD and absorption spectra of Ab(25–35) peptide in
methanol-d and DMSO-d6 solvents are shown in Fig. 1. For
comparative studies ECD spectra were also recorded in
methanol (Fig. 2 A). The ECD spectra in DMSO are not
useful for secondary structural analysis of peptides and
proteins due to interfering absorption from the solvent below
268 nm.
Previous reports on Ab peptide suggested that a physico-
chemical interaction of Ab peptides with a negatively
charged membrane surface might be responsible for the toxic
effect of Ab to neuronal cells (Hertel et al., 1997). Recent
studies also suggested that soluble Ab associates with lipid
bilayers and aggregates at the membrane surface (Lin et al.,
2001; Hirakura et al., 1998). In this context, methanol
provides a low dielectric environment simulating that
existing near the negatively charged membrane surface
(Bychkova et al., 1996). The structure of Ab(25–35) peptide
in methanol (a membrane-mimicking organic solvent), has
not been reported previously.
The VCD spectrum of Ab(25–35) peptide in methanol-
d (10 mg/mL) shows a negative band at 1614 cm1, an
intense positive band at 1628 cm1, and a weak negative
band at 1656 cm1 (Fig. 1, curve A). A similar ( 1, )-
type VCD pattern was also observed for b-sheet forming
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homooligopeptide, Boc-(L-Val)7-OMe, in triﬂuoroethanol
by Narayanan et al. (1986). Moreover, the appearance of
amide I band in the absorption spectrum (Fig. 1, curve A) at
1627 cm1 also indicates b-sheet structure. The appearance
of the weak absorption band at 1674 cm1 can be due to
antiparallel b-sheet conformation (Krimm and Bandekar,
1986). It should be noted (Vass et al., 2003) that both b-sheet
and b-turn structures exhibit absorption bands in the higher
frequency amide I region (1690–1670 cm1) along with
bands in the lower frequency amide I region (1640–1620
cm1). But Vass et al. suggested that the relative intensities
of b-turn bands (I16901670/I16401620 between 2:1 and 3:2)
are different from those for antiparallel b-sheets (I16901670/
I16401620 between 1:10 and 1:8). Since the relative
absorption intensity ratio, I1674/I1627 ¼ 1:2.4, for Ab(25–
35) peptide in methanol-d is in between that for antiparallel
b-sheet and b-turn structures, some amount of b-turn
conformation may not be ruled out. The ECD spectrum in
methanol at 10 mg/mL concentration (Fig. 2 A, curve a)
shows the negative band at 219 nm (n-p* transition) and
positive band at 208 nm with crossover point at 212 nm.
These bands are characteristic of peptides having pre-
dominantly b-sheet conformation. To study the concentra-
tion effect, the ECD measurements were also carried out at
a lower concentration of 5 mg/mL (Fig. 2 A, curve b). The
ECD spectrum at 5 mg/mL shows a negative band at ;218
nm, broader than that at 10 mg/mL, with crossover point at
209 nm. This suggests that the Ab(25–35) peptide adopts
predominantly b-sheet conformation at higher concen-
tration, and b-sheet along with some admixture of other
secondary structure at lower concentration. These results,
obtained at relatively higher concentration in methanol-d, are
relevant to Alzheimer’s disease since the mechanism of ﬁbril
formation of Ab peptides involved in AD depends on two
major factors, namely higher concentration of Ab peptide
and interaction of Ab peptide with membrane surfaces.
Previous reports (Terzi et al., 1994a,b) indicated that in
lipid environment, the attraction between cationic peptides
and negatively charged membrane facilitates b-sheet con-
formation for Ab(25–35) peptide. In the absence of lipid
environment, and at low concentration of peptide, random
coil conformation was preferred. In buffer solution at pH 7.4,
b-sheet conformation that was independent of concentration
has been suggested for Ab(25–35) peptide (Terzi et al.,
1994a). Even in triﬂuoroethanol, an a-helix promoting
solvent, ECD spectra suggested b-sheet conformation for
Ab(25–35) peptide (Laczko et al., 1994). In lithium dodecyl
sulfate micelles (Kohno et al., 1996), NMR spectral results
for Ab(25–35) peptide were interpreted in terms of short
a-helix in the C-terminal position. This study clearly sug-
gests the formation of b-sheet structure in methanol at the
concentrations employed.
One might question the relevance of DMSO to intra- or
extracellular conditions, but El-Agnaf et al. (1998) suggested
that DMSO is a pragmatic choice. This is based on the
observations of Sorimachi and Craik (1994), that DMSO
does not abolish the biological activity, and of Amodeo et al.
(1991), that the liquid phases in the cytoplasm and within
receptor-binding sites are characterized by higher viscosity
than bulk water. DMSO or another higher viscosity liquid
was suggested to be more realistic than water in modeling
these environments. In addition, DMSO is known to prevent
aggregation and precipitation of Ab peptides (Garzon-
Rodriguez et al., 1997; Shen and Murphy, 1995). Previous
structural analysis of Ab(25–35) peptide using NMR (El-
Agnaf et al., 1998) in DMSO suggested various possibilities
for secondary structure, including random coil, a linear
antiparallel b-sheet, or a b-hairpin. But in a different study
(Tauro et al., 2002), using two-dimensional NMR spectros-
copy, Ab(25–35) peptide was suggested to adopt a type I
b-turn around C-terminal residues (-Ile-Gly-Leu-Met-) in
DMSO-d6.
The VCD and vibrational absorption spectra of Ab(25–
35) peptide in DMSO-d6 (10 mg/mL) are shown in Fig. 1
(curve B). The major bands at 1690, 1669, and 1629 cm1
observed in the absorption spectrum (Fig. 1, curve B) of
Ab(25–35) peptide in DMSO-d6 indicates that b-turn
structure predominates. The relative intensity ratio, I1690/
FIGURE 1 VCD (left panel) and absorption
(right panel) spectra of Ab(25–35) peptide in
the amide I region in methanol-d (curve A)
and in DMSO-d6 (curve B), (concentration
10 mg/mL, path length 100 mM). The spectra
are shifted upwards for clarity.
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I1629 ¼ 3:2, for Ab(25–35) peptide in DMSO-d6 suggests
the presence of predominantly b-turn conformation. The
corresponding VCD spectrum (Fig. 1, curve B) shows
a negative band at 1663 cm1 and weak positive band at
1695 cm1, characteristic of b-turn conformation (Zhao
et al., 2000). These results suggest that the secondary
structure of Ab(25–35) peptide in DMSO-d6 is dominated by
solvent mediated b-turn. The S¼O group in DMSO-d6,
a strong hydrogen bond acceptor, will compete with C¼O
groups for hydrogen bonding with H–N of the peptide chain.
In DMSO-d6, sufﬁcient C¼O-H–N bonds are broken due to
competition of S¼O to form S¼O-H–N. In addition, some
broken C¼O-H–N groups may be free. The bands at higher
wavenumber probably reﬂect the absorption of free C¼O
groups. The bands in the 1645–1635 cm1 region for b-turn
structures are inﬂuenced by intramolecular hydrogen
bonding (Vass et al., 2003), which is probably responsible
for the strong negative VCD couplet (negative band at 1623
cm1 and positive band at 1635 cm1) unlike that in
methanol-d, where antiparallel b-sheet conformation is
implicated (vide supra). In methanol, the hydrogen bond
between polypeptide backbone and solvent is less favored,
resulting in a prominent b-sheet formation. It is worth noting
here that Ab(25–35) peptide was found, by two-dimensional
NMR spectroscopy (Tauro et al., 2002), to adopt a type I
b-turn around C-terminal residues (-Ile-Gly-Leu-Met-) in
DMSO-d6. Recently, Bond et al. (2003) have also shown by
the x-ray diffraction method that the C-terminal hydrophobic
residues (-Ile-Ile-Gly-Leu-Met-) adopt b-turn conformation.
Our VCD results on Ab(25–35) peptide in DMSO clearly
indicate the presence of predominantly b-turn conformation.
Conformation of Ab(25–35) peptide in gel state
The structure of Ab(25–35) peptide gel formed from
aqueous and organic solvents is reported here for the ﬁrst
time. The Ab(25–35) peptide gel was obtained separately in
methanol-d and acetate buffer (pD 3) after incubating the
stock solution (10 mg/mL) at room temperature for 24 h.
Acidic condition was chosen because it promotes the
formation of toxic ﬁbrils from Ab peptides (Su and Chang,
2001). Since acidic pH values have been shown to promote
the self-assembly of Ab, which seems to be responsible
for AD, elucidating the structure of Ab(25–35) in acidic en-
vironment at higher concentration may shed more light in
the self-assembly of Ab. In this case, Ab(25–35) peptide gel
formation in acetate buffer solution occurs in;2 h, which is
faster than the 15 h required for gel formation in methanol (as
observed by visual inspection). Fig. 3 shows the VCD and
absorption spectra of Ab(25–35) peptide gel in methanol-d
(curve A) and acetate buffer (curve B). The VCD spectrum in
methanol-d shows a weak negative band at ;1600 cm1, a
strong positive band at 1621 cm1, and a negative band at
1634/1650 cm1. A similar (, 1, )-type VCD spectrum
was noted earlier for Ab(25–35) peptide in methanol solu-
tion and also for b-sheet forming homooligopeptide, Boc-
(L-Val)7-OMe, both in ﬁlm and solution states, by
Narayanan et al. (1986). The vibrational absorption spectrum
of Ab(25–35) peptide gel derived from methanol-d (Fig. 3,
curve A) shows an intense amide I band at 1624 cm1, which
is due to b-sheet structure. The presence of a weak band at
1668 cm1 can be assigned to antiparallel b-sheet structure.
However, since the observed intensity ratio, I1668/I1624 ¼
1:3, is in between that for b-sheet and b-turn a small
proportion of b-turn structure may not be ruled out.
Recently, Bond et al. (2003) have suggested that Ab(25–
35) peptide takes a reverse turn at Gly33, which results in
intramolecular hydrogen bonding between the antiparallel
FIGURE 2 ECD spectra of Ab(25–35) peptide in methanol solution (A),
peptide gel formed in methanol (B), and in acetate buffer (pH 3) (C) at two
different concentrations. Curves a and b: 10 mg/mL and 5 mg/mL,
respectively.
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chains. The corresponding ECD spectrum (Fig. 2 B) of both
higher (10 mg/mL, curve a) and lower (5 mg/mL, curve b)
concentration gel formed in methanol, show a single intense
negative band around 218–220 nm and a positive band
around 197–199 nm with a crossover point around 208–209
nm, which are characteristic of peptides adopting b-sheet
conformation. In the case of Ab(25–35) peptide gel formed
in acetate buffer, VCD spectrum (Fig. 3, curve B) shows
similar VCD features (positive couplet with positive bias) as
observed in methanol (Fig. 3, curve A). However, in acetate
buffer, the spectrum shows a well-resolved negative band at
1651 cm1, unlike in methanol. The vibrational absorption
spectrum is similar to that observed for the gel formed from
methanol, except for minor frequency shifts and an addi-
tional weak band at ;1650 cm1. ECD spectra of the gel
formed in acetate buffer also indicate predominant b-sheet
structure both at higher (Fig. 2 C, curve a) and lower (Fig. 2
C, curve b) concentrations. A similar structural feature can
be deduced from ECD spectra in acetate buffer solution (Fig.
4 A). The gel formed from higher concentration solution
(Fig. 2 C, curve a) shows a greater baseline shift in the ECD
spectrum than that at lower concentration (Fig. 2 C, curve b).
This suggests that the size of the aggregate formed at higher
concentration is greater than that formed at lower concen-
tration.
Kinetics of Ab(25–35) peptide aggregation
The conformational events that occur after initial b-sheet
aggregate formation of Ab(25–35) peptide in methanol (10
mg/mL) were monitored by VCD and ECD. Here methanol
was used instead of methanol-d for VCD measurements,
because the hydrogen-deuterium exchange process involved
between amide protons and solvent can interfere with time-
dependent structural changes as inferred from changes in IR
absorption and VCD spectra. VCD and absorption spectra of
Ab(25–35) peptide in methanol at different time intervals
are presented in Fig. 5. The spectra show that the amide I
VCD bands have ( 1 )-type sign pattern with bands
at 1616, 1628, and 1666 cm1. Similar VCD sign pattern
was obtained for a b-sheet forming homooligopeptide,
Boc-(L-Val)7-OMe, in both solution and ﬁlm states, by
Narayanan et al. (1986). From the inspection of spectra at
different time intervals (Fig. 5, curves a to i), the VCD
FIGURE 3 VCD (left panel) and absorption
(right panel) spectra of Ab(25–35) peptide gel
formed in methanol-d (A) and acetate (pD 3)
buffer (B) (concentration 10 mg/mL). The
spectra are shifted upwards for clarity.
FIGURE 4 (A) ECD spectra of Ab(25–35) peptide in acetate buffer
solution (pH 3) at two different concentrations, (a) 10 mg/mL, and (b) 5 mg/
mL. (B) ECD spectra of Ab(25–35) peptide in methanol (10 mg/mL, path
length 0.01 cm) at different time intervals (h). Curves a through i: 0, 1, 2, 3,
4, 5, 6, 7, and 24 h.
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intensities of Ab peptide at 1628 and 1616 cm1 are seen to
increase with time, but the VCD intensity of the weak band
at 1666 cm1 did not change signiﬁcantly. The VCD intensi-
ties seen in the 1675–1700 cm1 region are too weak to draw
any deﬁnitive conclusions. In the absorption spectrum, the
intensity of 1675 cm1 band is seen to remain constant and
that of 1627 cm1 band is seen to increase with time for up to
9 h, with the intensity ratio I1675/I1627 being around 1:3.
However, for reasons that are not clear, the last two
absorption spectra, taken at 18 and 47.5 h, show an overall
baseline shift and increased intensity at 1675 cm1. One
possible explanation for this could be scattering resulting
from the aggregate formation at these later times. The
corresponding time-dependent ECD (Fig. 4 B) shows
b-sheet spectra, characterized by the presence of a nega-
tive band at 220 nm with crossover point at 211 nm. There
is a small time-dependent change in the intensity of the CD
band at 220 nm and also in the crossover point. During the
incubation period, the series of ECD spectra (Fig. 4 B, curves
a to i) at different time intervals are very similar to the
spectrum at 0 h, but the crossover points indicate a small red
shift in the wavelength. This indicates a distinct structural
change as suggested by previous research groups (Maeda,
1987; Maeda and Ooi, 1981; Saito et al., 1982). A similar
type of red shift in the crossover point was previously
observed for islet amyloid polypeptide in aqueous buffer
solution (Kayed et al., 1999).
Variation of VCD intensity (at 1628 cm1) with time (Fig.
6 A) for Ab(25–35) peptide in methanol shows that the slope
of intensity versus time curve changes at ;7 h. This may
suggest that a saturation of b-structure formation occurs at
;7 h. The change in ECD intensity (molar ellipticity) at 216
nm (Fig. 6 B) with time also shows that the slope changes at
;7 h, which is in good agreement with that concluded from
the VCD results (Fig. 6 A). However, the spectral changes
with time were more clearly observed with VCD (amide I
region) than with ECD. This observation suggests that VCD
is a comparatively more sensitive method in the determina-
tion of kinetics of Ab(25–35) peptide aggregation.
Conformation of Ab(25–35) peptide ﬁlm
The conformation of Ab(25–35) peptide ﬁlm was also
analyzed using vibrational absorption and VCD. Films were
tested for satisfactory VCD characteristics by comparison of
the ﬁlm VCD obtained with the sample rotated at different
angles (90, 180, and 270) around the light beam axis. The
corresponding VCD and absorption spectra are depicted in
Fig. 7, where the VCD sign patterns can be seen to be
orientation-independent. The spectra show a negative band
at 1609 cm1, a positive band at 1640 cm1, and a weak
positive shoulder at 1670 cm1. Compared to the VCD
FIGURE 5 VCD (left panel) and absorption
(right panel) spectra of Ab(25–35) peptide in
methanol solution (10 mg/mL, path length 50
mm) at different time intervals (h). (a) 0, (b) 1,
(c) 2, (d) 4, (e) 6.5, (f) 7.5, (g) 9, (h) 18, and (i)
47.5.
FIGURE 6 Time-dependent changes in spectral intensities in methanol.
(A) Variation of VCD intensity at 1628 cm1. (B) Variation of ECD intensity
at 216 nm.
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spectrum in methanol-d solution (Fig. 1, left panel) the
positive VCD band for the ﬁlm is blue-shifted. The weak
positive shoulder at 1670 cm1 seen in the ﬁlm VCD
spectrum is also blue-shifted and is opposite in sign to that
seen in solution at 1656 cm1 (Fig. 1, left panel). Neverthe-
less, the corresponding IR absorption spectrum of ﬁlm (Fig.
7) shows a weak band at 1665 cm1 and an intense band at
1625 cm1, with an intensity ratio of 1:2.5, which may be
assigned to a mixture of b-sheet and b-turn structures. This
observation is consistent with that in a previous study (Bond
et al., 2003), where solubilized peptide after subsequent
drying was determined from x-ray diffraction pattern to have
b-sheet structure. Bond et al. (2003) have also indicated that
the hydrophobic Ab(31–35) residue (Ile-Ile-Gly-Leu-Met) is
involved in a turn conformation.
CONCLUSIONS
This study addresses the question of the structure of Ab(25–
35) peptide at higher concentration in membraneous
(methanol), aggregated (acidic solution), and nonaggregated
(DMSO) conditions using VCD, IR absorption, and ECD
spectroscopy. Based on these spectroscopic results, the
Ab(25–35) peptide was found to adopt predominantly
b-sheet structure in methanol solution, in the gel (formed
from methanol or acidic acetate buffer), and in the ﬁlm
prepared from methanol solution by evaporation. Time-
dependent measurements in methanol solution, monitoring
the aggregation process, indicate that the saturation of
b-sheet formation occurs at ;7 h. Based on the current and
previous studies on Ab(25–35) peptide, it can be suggested
that the ﬁve residues, from Ile (31) to Met (35), at the
C-terminal end form a b-turn conformation and that the
remaining residues, 25–30, participate in interpeptide
b-sheet formation. However, solvent mediated b-turn ap-
pears to dominate in DMSO-d6 solution. This work also
demonstrates that VCD is a measurable and useful property
for structural elucidation of amyloid-forming peptides in
different conditions (solution, gel, and dry thin ﬁlm). A
combination of VCD with IR and ECD methods is seen to
help in analyzing the structure of Ab(25–35) peptide, more
than if only one of these methods is used. We hope to
undertake future studies in the conformational analysis of
other amyloid peptides including prion, polyglutamine, and
islet amyloid polypeptides under different environments.
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